Hello, Guest!

Tag: drug review

Palantir to Help FDA Review, Approve Drugs Under Three-Year ContractContract Awards

Palantir to Help FDA Review, Approve Drugs Under Three-Year Contract

Palantir Technologies (NYSE: PLTR) has received a potential three-year, $44.4M contract from the Food and Drug Administration to provide software…